# FutuRx

FutuRx is an Asset Manager based in Ness Ziona, Israel.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Ness Ziona, Israel
- **Region:** Middle East
- **Address:** 2 Ilan Ramon St., 3rd Floor, Ness Ziona, 7403635, Israel
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.futurx.co.il
- **LinkedIn:** https://www.linkedin.com/company/futurx

## Regulatory record

- **Reports private funds:** No

## About

FutuRx is a Venture Capital investment company based in Ness Ziona, Israel. It has a team of 9 staff, with 4 investment professionals.

## Sectors

- Pharmaceuticals
- Biotechnology

## People

- Dr. Kinneret Savitzky — CEO
- Modi Teicher — Chief Business Officer
- Aric Orbach — Chief Technology Officer
- Lior Teitelbaum — Co-founder and former CBO

## Questions

### How does FutuRx source its pipeline?

FutuRx sources therapeutic programs primarily from the Weizmann Institute of Science, working closely with its technology transfer office, Yeda. It also reviews assets from other Israeli universities and research hospitals. The incubator's physical location in the Weizmann Science Park enables early access to academic discoveries before they are broadly marketed to external venture investors.

### Does FutuRx participate in fund commitments or only direct deals?

FutuRx primarily creates and seeds new portfolio companies from academic intellectual property rather than making fund commitments to outside managers. Each incubated startup receives lab space, management support, and initial capital within the Ness Ziona facility. The firm is not known to operate a fund-of-funds program or allocate capital to third-party venture vehicles.

### What therapeutic areas does FutuRx target?

The incubator has historically focused on oncology, immunology, and neuroscience, reflecting both the strengths of the Weizmann Institute and the strategic interests of its pharmaceutical limited partners. Individual portfolio companies have pursued small-molecule drugs, biologics, and platform technologies. FutuRx's mandate supports preclinical and early clinical-stage programs with clear paths to pharmaceutical partnerships or acquisitions.

### How is FutuRx related to the Weizmann Institute of Science?

FutuRx is a separate legal entity but operates as a close collaborator of the Weizmann Institute. Its laboratory and offices are located in the Weizmann Science Park in Ness Ziona. The incubator licenses intellectual property from Weizmann through Yeda, the institute's technology transfer arm, and commercializes academic research through newly formed companies.

## Related profiles

- [Futurum Ventures](https://altss.com/profile/futurum-ventures)
- [Futury Capital](https://altss.com/profile/futury-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/futurx

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology